Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429 · see citing works

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948 · see citing works

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637 · see citing works

J. Virol. Methods

Singh, R. P., Kurz, J., & Boiteau, G. (1996) · Journal of Virological Methods · doi:10.1016/0166-0934(96)02096-4 · Cited by 2,554 · see citing works

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,508 · see citing works

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,189 · see citing works

Effects of cytochalasin and phalloidin on actin.

Cooper, J. A. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.4.1473 · Cited by 2,009 · see citing works

Gold nanocages covered by smart polymers for controlled release with near-infrared light

Yavuz, M. S., Cheng, Y., Chen, J., Cobley, C. M., Zhang, Q., Rycenga, M., Xie, J., Kim, C., Song, K. H., Schwartz, A. G., et al. (2009) · Nature Materials · doi:10.1038/nmat2564 · Cited by 1,404 · see citing works

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K. S., Jensen, K., Breen, W., Hartsough, K. C., Machemer, L., Radka, S. F., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168 · see citing works

Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras

McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,005 · see citing works

Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes

Matranga, C., Tomari, Y., Shin, C., Bartel, D. P., & Zamore, P. D. (2005) · Cell · doi:10.1016/j.cell.2005.08.044 · Cited by 969 · see citing works

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

Bartlett, D. W., Su, H. C., Hildebrandt, I. J., Weber, W., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 808 · see citing works

Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins

Holness, C. L. L., & Simmons, D. (1993) · Blood · doi:10.1182/blood.v81.6.1607.1607 · Cited by 716 · see citing works

Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes

Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703778104 · Cited by 658 · see citing works

CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens

Helmy, K. Y., Katschke, K. J., Gorgani, N. N., Kljavin, N. M., Elliott, J. M., Diehl, L. J., Scales, S. J., Ghilardi, N., & Campagne, M. V. L. (2006) · Cell · doi:10.1016/j.cell.2005.12.039 · Cited by 629 · see citing works

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors

Dassie, J. P., Liu, X., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., & Giangrande, P. H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1560 · Cited by 591 · see citing works

Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation

Aouadi, M., Tesz, G. J., Nicoloro, S. M. C., Wang, M., Chouinard, M., Soto, E. R., Ostroff, G. R., & Czech, M. (2009) · Nature · doi:10.1038/nature07774 · Cited by 572 · see citing works

Lipid-based systemic delivery of siRNA

Tseng, Y.-C., Mozumdar, S., & Huang, L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.003 · Cited by 463 · see citing works

Cleavage of the siRNA passenger strand during RISC assembly in human cells

Leuschner, P. J. F., Ameres, S. L., Kueng, S., & Martı̂nez, J. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400637 · Cited by 399 · see citing works

Efficient and targeted delivery of siRNA in vivo

Shim, M. S., & Kwon, Y. J. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07904.x · Cited by 311 · see citing works

The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68.

Ramprasad, M. P., Fischer, W., Witztum, J. L., Sambrano, G. R., Quehenberger, O., & Steinberg, D. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9580 · Cited by 311 · see citing works

miRNA in situ hybridization in formaldehyde and EDC–fixed tissues

Pena, J., Sohn-Lee, C., Rouhanifard, S. H., Ludwig, J., Hafner, M., Mihailovic, A., Lim, C., Holoch, D., Berninger, P., Zavolan, M., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1294 · Cited by 292 · see citing works

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†

Morrissey, D. V., Blanchard, K. S., Shaw, L., Jensen, K., Lockridge, J. A., Dickinson, B., McSwiggen, J. A., Vargeese, C., Bowman, K., Shaffer, C. S., et al. (2005) · Hepatology · doi:10.1002/hep.20702 · Cited by 291 · see citing works

Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse

Dambach, D. M., Watson, L. M., Gray, K. R., Durham, S. K., & Laskin, D. L. (2002) · Hepatology · doi:10.1053/jhep.2002.33162 · Cited by 289 · see citing works

The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice

Gao, S., Dagnæs‐Hansen, F., Nielsen, E. J. B., Wengel, J., Besenbacher, F., Howard, K. A., & Kjems, J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.91 · Cited by 287 · see citing works

Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice

Kinoshita, M., Uchida, T., Sato, A., Nakashima, M., Nakashima, H., Shono, S., Habu, Y., Miyazaki, H., Hiroi, S., & Seki, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.037 · Cited by 282 · see citing works

New Insights into Functional Aspects of Liver Morphology

Malarkey, D. E., Johnson, K. A., Ryan, L., Boorman, G. A., & Maronpot, R. R. (2005) · Toxicologic Pathology · doi:10.1080/01926230590881826 · Cited by 235 · see citing works

Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification

Silahtaroglu, A., Nolting, D. S., Dyrskjøt, L., Berezikov, E., Møller, M., Tommerup, N., & Kauppinen, S. (2007) · Nature Protocols · doi:10.1038/nprot.2007.313 · Cited by 227 · see citing works

Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics

Nagayama, S., Ogawara, K., Fukuoka, Y., Higaki, K., & Kimura, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.036 · Cited by 225 · see citing works

Endotoxin-induced cytokine gene expression and excretion in the liver

Luster, M. I., Germolec, D. R., Yoshida, T., Kayama, F., & Thompson, M. B. (1994) · Hepatology · doi:10.1002/hep.1840190229 · Cited by 224 · see citing works

Hepatocyte Antigen as a Marker of Hepatocellular Carcinoma

Chu, P. G., Ishizawa, S., Wu, E., & Weiss, L. M. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200208000-00002 · Cited by 222 · see citing works

A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery

Lu, J. J.-Q., Langer, R., & Chen, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900023v · Cited by 219 · see citing works

Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment

Abrams, M. T., Koser, M. L., Seitzer, J., Williams, S. C., DiPietro, M. A., Wang, W., Shaw, A. W., Mao, X., Jadhav, V., Davide, J. P., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.208 · Cited by 209 · see citing works

Polymersome delivery of siRNA and antisense oligonucleotides

Kim, Y.-H., Tewari, M., Pajerowski, J. D., Cai, S., Sen, S., Williams, J. H., Sirsi, S. R., Lutz, G. J., & Discher, D. E. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.020 · Cited by 185 · see citing works

Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: Effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging

Merkel, O. M., Librizzi, D., Pfestroff, A., Schurrat, T., Buyens, K., Sanders, N. N., Smedt, S. C. D., Béhé, M. P., & Kissel, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.016 · Cited by 183 · see citing works

Cellular organization of normal mouse liver: a histological, quantitative immunocytochemical, and fine structural analysis

Baratta, J. L., Ngo, A., Lopez, B., Kasabwalla, N., Longmuir, K. J., & Robertson, R. T. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0577-1 · Cited by 181 · see citing works

Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3

Cattori, V., van Montfoort, J. E., Stieger, B., Landmann, L., Meijer, D. K. F., Winterhalter, K. H., Meier, P. J., & Hagenbuch, B. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100697 · Cited by 175 · see citing works

Therapeutic Applications of DNA and RNA Aptamers

Thiel, K. W., & Giangrande, P. H. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0199 · Cited by 173 · see citing works

Lentiviral delivery of short hairpin RNAs

Manjunath, N., Wu, H., Subramanya, S., & Shankar, P. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.004 · Cited by 165 · see citing works

Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors

Schiedner, G., Hertel, S., Johnston, M., Dries, V., van Rooijen, N., & Kochanek, S. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00017-5 · Cited by 148 · see citing works

Isolation and analysis of cDNA clones expressing human lupus La antigen.

Chambers, J. C., & Keene, J. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2115 · Cited by 146 · see citing works

Effect of Poly(N-vinyl-pyrrolidone)-block-poly( d , l -lactide) as Coating Agent on the Opsonization, Phagocytosis, and Pharmacokinetics of Biodegradable Nanoparticles

Gaucher, G., Asahina, K., Wang, J., & Leroux, J. (2009) · Biomacromolecules · doi:10.1021/bm801178f · Cited by 132 · see citing works

In Vivo SPECT and Real-Time Gamma Camera Imaging of Biodistribution and Pharmacokinetics of siRNA Delivery Using an Optimized Radiolabeling and Purification Procedure

Merkel, O. M., Librizzi, D., Pfestroff, A., Schurrat, T., Béhé, M. P., & Kissel, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800408g · Cited by 106 · see citing works

Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequences for RNA-binding

Chan, E. K. L., Sullivan, K. F., & Tan, E. M. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.6.2233 · Cited by 96 · see citing works

Keratins modulate hepatic cell adhesion, size and G1/S transition

Galarneau, L., Loranger, A., Gilbert, S., & Marceau, N. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.007 · Cited by 94 · see citing works

Species differences in transgene DNA uptake in hepatocytes after adenoviral transfer correlate with the size of endothelial fenestrae

Snoeys, J., Lievens, J., Wisse, E., Jacobs, F., Duimel, H., Collen, D., Frederik, P. M., & Geest, B. D. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302899 · Cited by 87 · see citing works

Dicer is required for proper liver zonation

Sekine, S., Ogawa, R., McManus, M. T., Kanai, Y., & Hebrok, M. (2009) · The Journal of Pathology · doi:10.1002/path.2606 · Cited by 85 · see citing works

Tracking the Relative In Vivo Pharmacokinetics of Nanoparticles with PARACEST MRI

Ali, M. M., Yoo, B., & Pagel, M. D. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900040u · Cited by 78 · see citing works

Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films

Dimitrova, M., Affolter, C., Meyer, F., Nguyen, I., Richard, D., Schuster, C., Bartenschlager, R. F. W., Voegel, J., Ogier, J., & Baumert, T. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800156105 · Cited by 75 · see citing works

Challenges and Opportunities for Local and Systemic Delivery of siRNA and Antisense Oligonucleotides

Sepp‐Lorenzino, L., & Ruddy, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.174 · Cited by 65 · see citing works

BARRIERS TO SUCCESSFUL DELIVERY OF SHORT INTERFERING RNA AFTER SYSTEMIC ADMINISTRATION

White, P. J. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04992.x · Cited by 61 · see citing works

Expression of CD163 in the liver of patients with viral hepatitis

Hiraoka, A., Horiike, N., Akbar, S. M. F., Michitaka, K., Matsuyama, T., & Onji, M. (2005) · Pathology - Research and Practice · doi:10.1016/j.prp.2004.10.006 · Cited by 59 · see citing works

Noninvasive Imaging of Lipid Nanoparticle–Mediated Systemic Delivery of Small-Interfering RNA to the Liver

Tao, W., Davide, J. P., Cai, M., Zhang, G., South, V. J., Matter, A. M., Ng, B., Zhang, Y., & Sepp‐Lorenzino, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.147 · Cited by 57 · see citing works

Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy

Chen, Y., & Huang, L. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802568505 · Cited by 55 · see citing works

Influence of PEG chain on the complement activation suppression and longevity in vivo prolongation of the PCL biomedical nanoparticles

Shan, X., Yuan, Y., Liu, C., Tao, X., Sheng, Y., & Xu, F. L. (2009) · Biomedical Microdevices · doi:10.1007/s10544-009-9336-2 · Cited by 55 · see citing works

Receptor-mediated endocytosis of lactate dehydrogenase M4 by liver macrophages: a mechanism for elimination of enzymes from plasma. Evidence for competition by creatine kinase MM, adenylate kinase, malate, and alcohol dehydrogenase.

Smit, M. J., Duursma, A. M., Bouma, J. M. W., & Gruber, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45160-5 · Cited by 55 · see citing works

Altered hepatic localization and expression of occludin after common bile duct ligation

Fallon, M. B., Brecher, A. R., Balda, M. S., Matter, K., & Anderson, J. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.269.4.c1057 · Cited by 53 · see citing works

Involvement of annexin I and annexin II in hepatocyte proliferation: Can annexins I and II be markers for proliferative hepatocytes?

Masaki, T., Tokuda, M., Fujimura, T., Ohnishi, M., Tai, Y., Miyamoto, K., Itano, T., Matsui, H., Watanabe, S., Sogawa, K.-I., et al. (1994) · Hepatology · doi:10.1002/hep.1840200224 · Cited by 51 · see citing works

A quantitative evaluation of peroxidase inhibitors for tyramide signal amplification mediated cytochemistry and histochemistry

Liu, G., Amin, S., Okuhama, N. N., Liao, G., & Mingle, L. A. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0161-x · Cited by 49 · see citing works

Stem-Loop RT-PCR Quantification of siRNAs In Vitro and In Vivo

Cheng, A., Li, M., Liang, Y., Wang, Y., Wong, L., Chen, C., Vlassov, A. V., & Magdaleno, S. M. (2009) · Oligonucleotides · doi:10.1089/oli.2008.0176 · Cited by 48 · see citing works

Neutrophils Sequestered in the Liver Suppress the Proinflammatory Response of Kupffer Cells to Systemic Bacterial Infection

Holub, M., Cheng, C., Mott, S., Wintermeyer, P., van Rooijen, N., & Gregory, S. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803041 · Cited by 44 · see citing works

Overcoming obstacles to develop effective and safe siRNA therapeutics

Li, L., & Shen, Y. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902911420 · Cited by 41 · see citing works

A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells

Smith, J. S., Xu, Z., & Byrnes, A. P. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2007.08.009 · Cited by 38 · see citing works

Efficient Inhibition of Hepatitis B Virus Replication In Vivo , Using Polyethylene Glycol-Modified Adenovirus Vectors

Crowther, C. E., Ely, A., Hornby, J., Mufamadi, M. S., Salazar, F. H., Marion, P. L., & Arbuthnot, P. B. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.066 · Cited by 38 · see citing works

Annexin A3 Expression Increases in Hepatocytes and is Regulated by Hepatocyte Growth Factor in Rat Liver Regeneration

Harashima, M., Harada, K., Ito, Y., Hyuga, M., Seki, T., Ariga, T., Yamaguchi, T., & Niimi, S. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm248 · Cited by 35 · see citing works

Human C-Reactive Protein Does Not Protect against Acute Lipopolysaccharide Challenge in Mice

Hirschfield, G. M., Herbert, J., Kahan, M., & Pepys, M. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6046 · Cited by 34 · see citing works

Failure of hepatocyte marker-expressing hematopoietic progenitor cells to efficiently convert into hepatocytes in vitro

Lian, G., Wang, C., Teng, C., Zhang, C., Du, L., Zhong, Q., Miao, C., Ding, M., & Deng, H. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2005.12.004 · Cited by 32 · see citing works

Sjögren's syndrome nuclear antigen B (La): cDNA cloning, structural domains, and autoepitopes

Chan, E. K. L., Sullivan, K. F., Fox, R. I., & Tan, E. M. (1989) · Journal of Autoimmunity · doi:10.1016/0896-8411(89)90159-5 · Cited by 30 · see citing works

Peptide Mediated siRNA Delivery

Jafari, M., & Chen, P. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630839 · Cited by 30 · see citing works

Systemic siRNA delivery to leukocyte-implicated diseases

Peer, D., & Shimaoka, M. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7936 · Cited by 28 · see citing works

Systemic Delivery and Quantification of Unformulated Interfering RNAs In Vivo

Morin, A., Gallou‐Kabani, C., Mathieu, J. R. R., & Cabon, F. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630820 · Cited by 17 · see citing works

Effect of biological matrix and sample preparation on qPCR quantitation of siRNA drugs in animal tissues

Seitzer, J. L., Zhang, H., Koser, M. L., Pei, Y., & Abrams, M. T. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.09.005 · Cited by 16 · see citing works

EFFICIENT INHIBITION OF HEPATITIS B VIRUS REPLICATION IN VIVO USING PEG-MODIFIED ADENOVIRUS VECTORS

Crowther, C. E., Ely, A., Hornby, J., Mufamadi, M. S., Salazar, F. H., Marion, P. L., & Arbuthnot, P. B. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.066 · Cited by 15 · see citing works

Quantitative evaluation of lysozyme- and CD68-positive Kupffer cells in diethylnitrosamine-induced hepatocellular carcinomas in monkeys

Lapis, K., Zalatnai, A., Timár, F., & Thorgeirsson, U. P. (1995) · Carcinogenesis · doi:10.1093/carcin/16.12.3083 · Cited by 14 · see citing works

Flow cytometric measurement of phagocytosis reveals a role for C3b in metal particle uptake by phagocytes

Baldwin, L., Flanagan, B., & Hunt, J. A. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30252 · Cited by 9 · see citing works

Major Determinants in Hepatic Disposition of Polystyrene Nanospheres: Implication for Rational Design of Particulate Drug Carriers;

Ogawara, K., Higaki, K., & Kimura, T. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i45.10 · Cited by 7 · see citing works

Characterization of the gene delivery properties of baculoviral-based virosomal vectors

Guibinga, G.-H., Song, S., Loring, J. F., & Friedmann, T. (2008) · Journal of Virological Methods · doi:10.1016/j.jviromet.2007.11.007 · Cited by 7 · see citing works

Development and Application of Glycosylated Particulate Carriers for Delivery of Nucleic Acid Medicine

Kawakami, S. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.1743 · Cited by 6 · see citing works

Knocking down disease: a progress report on siRNA therapeutics

Wittrup, A., & Lieberman, J. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3978 · Cited by 810 · see citing works

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Rosenblum, D., Gutkin, A., Kedmi, R., Ramishetti, S., Veiga, N., Jacobi, A. M., Schubert, M. S., Friedmann-Morvinski, D., Cohen, Z. R., Behlke, M. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc9450 · Cited by 614 · see citing works

Overcoming Endosomal Entrapment in Drug Delivery

Pei, D., & Buyanova, M. Y. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00778 · Cited by 405 · see citing works

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

Hammond, S. M., Aartsma-Rus, A. M., Alves, S., Borgos, S. E., Buijsen, R. A. M., Collin, R. W. J., Covello, G., Denti, M. A., Desviat, L. R., Echevarría, L., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013243 · Cited by 395 · see citing works

Lipid nanoparticle technology for therapeutic gene regulation in the liver

Witzigmann, D., Kulkarni, J. A., Leung, J., Chen, S., Cullis, P. R., & van der Meel, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.026 · Cited by 376 · see citing works

Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of <i>in vivo</i> imaging

Jung, H. N., Lee, S.-Y., Lee, S., Youn, H., & Im, H.-J. (2022) · Theranostics · doi:10.7150/thno.77259 · Cited by 282 · see citing works

Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles

Kanasty, R. L., Whitehead, K. A., Vegas, A. J., & Anderson, D. G. (2012) · Molecular Therapy · doi:10.1038/mt.2011.294 · Cited by 281 · see citing works

Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver

Zhang, R., El-Mayta, R. D., Murdoch, T. J., Warzecha, C. C., Billingsley, M. M., Shepherd, S. J., Gong, N., Wang, L., Wilson, J. M., Lee, D., et al. (2020) · Biomaterials Science · doi:10.1039/d0bm01609h · Cited by 261 · see citing works

mRNA transcript therapy

Weissman, D. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.973859 · Cited by 228 · see citing works

Progress Toward In Vivo Use of siRNAs-II

Rettig, G. R., & Behlke, M. A. (2011) · Molecular Therapy · doi:10.1038/mt.2011.263 · Cited by 217 · see citing works

Imaging small molecule-induced endosomal escape of siRNA

Rietz, H. D., Hedlund, H., Wilhelmson, S., Nordenfelt, P., & Wittrup, A. (2020) · Nature Communications · doi:10.1038/s41467-020-15300-1 · Cited by 203 · see citing works

Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System

Pattipeiluhu, R., Arias‐Alpizar, G., Basha, G., Chan, K. Y. T., Bussmann, J., Sharp, T. H., Moradi, M., Sommerdijk, N., Harris, E. N., Cullis, P. R., et al. (2022) · Advanced Materials · doi:10.1002/adma.202201095 · Cited by 194 · see citing works

Lipid nanoparticle-mediated drug delivery to the brain

Khare, P., Edgecomb, S. X., Hamadani, C. M., Tanner, E. E. L., & S Manickam, D. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114861 · Cited by 187 · see citing works

Understanding Nanomaterial–Liver Interactions to Facilitate the Development of Safer Nanoapplications

Li, J., Chen, C., & Xia, T. (2022) · Advanced Materials · doi:10.1002/adma.202106456 · Cited by 165 · see citing works

Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia

Nabhan, J. F., Wood, K. M., Rao, V. P., Morin, J., Bhamidipaty, S., LaBranche, T. P., Gooch, R. L., Bozal, F., Bulawa, C. E., & Guild, B. C. (2016) · Scientific Reports · doi:10.1038/srep20019 · Cited by 140 · see citing works

siRNA Delivery to the lung: What's new?

Merkel, O. M., Rubinstein, I., & Kissel, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.018 · Cited by 132 · see citing works

Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs

Luozhong, S., Yuan, Z., Sarmiento, T., Chen, Y., Gu, W., McCurdy, C., Gao, W., Li, R., Wilkens, S., & Jiang, S. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03234 · Cited by 128 · see citing works

Single-cell analysis reveals effective siRNA delivery in brain tumors with microbubble-enhanced ultrasound and cationic nanoparticles

Guo, Y., Lee, H., Fang, Z., Velalopoulou, A. P., Kim, J., Thomas, M. B., Liu, J., Abramowitz, R. G., Kim, Y., Coskun, A. F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf7390 · Cited by 114 · see citing works

Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines

Park, J., Park, J., Pei, Y., Xu, J., & Yeo, Y. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.004 · Cited by 114 · see citing works

The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery

Kularatne, R. N., Crist, R. M., & Stern, S. T. (2022) · Pharmaceuticals · doi:10.3390/ph15070897 · Cited by 109 · see citing works

Small RNA Detection by in Situ Hybridization Methods

Urbanek-Trzeciak, M. O., Nawrocka, A., & Krzyżosiak, W. J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613259 · Cited by 105 · see citing works

Efficient Delivery of Antisense Oligonucleotides Using Bioreducible Lipid Nanoparticles In Vitro and In Vivo

Yang, L., Ma, F., Liu, F., Chen, J., Zhao, X., & Xu, Q. (2020) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2020.01.018 · Cited by 103 · see citing works

Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides

Hou, K. K., Pan, H., Ratner, L., Schlesinger, P. H., & Wickline, S. A. (2013) · ACS Nano · doi:10.1021/nn403311c · Cited by 95 · see citing works

mRNA: A Novel Avenue to Antibody Therapy?

Schlake, T., Thran, M., Fiedler, K., Heidenreich, R., Petsch, B., & Fotin‐Mleczek, M. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.002 · Cited by 90 · see citing works

Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo

Zhang, T., Yin, H., Li, Y., Yang, H., Ge, K., Zhang, J., Yuan, Q., Dai, X., Naeem, A., Weng, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109804 · Cited by 94 · see citing works

Nucleic Acid Drugs—Current Status, Issues, and Expectations for Exosomes

Yamada, Y. (2021) · Cancers · doi:10.3390/cancers13195002 · Cited by 89 · see citing works

Injectable, Guest–Host Assembled Polyethylenimine Hydrogel for siRNA Delivery

Wang, L. L., Sloand, J. N., Gaffey, A. C., Venkataraman, C. M., Wang, Z., Trubelja, A., Hammer, D. A., Atluri, P., & Burdick, J. A. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b01378 · Cited by 87 · see citing works

siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases

Kalita, T., Dezfouli, S. A., Pandey, L. M., & Uludağ, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112520 · Cited by 87 · see citing works

Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA

Liu, X., Wang, W., Samarsky, D. A., Liu, L., Xu, Q., Zhang, W., Zhu, G., Wu, P., Zuo, X., Deng, H., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku831 · Cited by 81 · see citing works

Toxicological profile of lipid-based nanostructures: are they considered as completely safe nanocarriers?

Azarnezhad, A., Samadian, H., Jaymand, M., Sobhani, M., & Ahmadi, A. (2020) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1719974 · Cited by 81 · see citing works

Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics

Vervaeke, P., Borgos, S. E., Sanders, N. N., & Combes, F. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114236 · Cited by 74 · see citing works

Insight into Mechanisms of Cellular Uptake of Lipid Nanoparticles and Intracellular Release of Small RNAs

Yu, B., Wang, X., Zhou, C., Teng, L., Ren, W., Yang, Z., Shih, C., Wang, T., Lee, R. J., Tang, S.-Q., et al. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1366-7 · Cited by 72 · see citing works

Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach

Young, R. E., Nelson, K. M., Hofbauer, S. I., Vijayakumar, T., Alameh, M., Weissman, D., Papachristou, C., Gleghorn, J. P., & Riley, R. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.11.014 · Cited by 73 · see citing works

Aerosol delivery of stabilized polyester-siRNA nanoparticles to silence gene expression in orthotopic lung tumors

Yan, Y., Zhou, K., Xiong, H., Miller, J. B., Motea, E. A., Boothman, D. A., Liu, L., & Siegwart, D. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.001 · Cited by 68 · see citing works

Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies

Anwar, S., Mir, F., & Yokota, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041130 · Cited by 63 · see citing works

Current and prospective control strategies of influenza A virus in swine

Salvesen, H. A., & Whitelaw, B. (2021) · Porcine Health Management · doi:10.1186/s40813-021-00196-0 · Cited by 58 · see citing works

Therapeutic RNA-silencing oligonucleotides in metabolic diseases

Goga, A., & Stoffel, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00407-5 · Cited by 58 · see citing works

Delivery and Biodistribution of siRNA for Cancer Therapy: Challenges and Future Prospects

Seth, S., Johns, R. E., & Templin, M. V. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.155 · Cited by 58 · see citing works

Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo

Segal, M., Biscans, A., Gilles, M.-E., Anastasiadou, E., Luca, R. D., Lim, J., Khvorova, A., & Slack, F. J. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.008 · Cited by 58 · see citing works

Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol

Neary, M. T., Mulder, L. M., Kowalski, P. S., MacLoughlin, R. J., Crean, A. M., & Ryan, K. B. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.012 · Cited by 62 · see citing works

Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis

Liu, H., Pietersz, G. A., Peter, K., & Wang, X. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01279-y · Cited by 51 · see citing works

Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension

Olearczyk, J., Gao, S., Eybye, M. E., Yendluri, S., Andrews, L. E., Bartz, S. R., Cully, D. F., & Tadin‐Strapps, M. (2013) · Hypertension Research · doi:10.1038/hr.2013.155 · Cited by 50 · see citing works

RNA Therapeutics: How Far Have We Gone?

Coutinho, M. F., Matos, L., Santos, J. I., & Alves, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-19966-1_7 · Cited by 44 · see citing works

Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art

Rhym, L. H., & Anderson, D. G. (2022) · Med · doi:10.1016/j.medj.2022.02.001 · Cited by 45 · see citing works

MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics

Varshney, J., & Subramanian, S. (2015) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2015.00031 · Cited by 39 · see citing works

MicroRNA Regulation of Airway Inflammation and Airway Smooth Muscle Function: Relevance to Asthma

Deshpande, D. A., Dileepan, M., Walseth, T. F., Subramanian, S., & Kannan, M. (2015) · Drug Development Research · doi:10.1002/ddr.21267 · Cited by 39 · see citing works

Application of microphysiological systems in biopharmaceutical research and development

Peterson, N. C., Mahalingaiah, P. K. S., Fullerton, A. M., & Piazza, M. (2020) · Lab on a Chip · doi:10.1039/c9lc00962k · Cited by 39 · see citing works

Boosting ionizable lipid nanoparticle-mediated in vivo mRNA delivery through optimization of lipid amine-head groups

Ding, F., Zhang, H., Cui, J., Li, Q., & Yang, C. (2021) · Biomaterials Science · doi:10.1039/d1bm00866h · Cited by 37 · see citing works

Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host

Thibault, P. A., & Wilson, J. A. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.03.004 · Cited by 35 · see citing works

Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia

Landry, B. K., Valencia‐Serna, J., Gül-Uludağ, H., Jiang, X., Janowska‐Wieczorek, A., Brandwein, J. M., & Uludağ, H. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.13 · Cited by 35 · see citing works

Recommendations of the Oligonucleotide Safety Working Group's Formulated Oligonucleotide Subcommittee for the Safety Assessment of Formulated Oligonucleotide-Based Therapeutics

Marlowe, J. L., Akopian, V., Karmali, P. P., Kornbrust, D. J., Lockridge, J. A., & Semple, S. C. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0671 · Cited by 32 · see citing works

Engineering pH‐Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics

Boloix, A., Feiner‐Gracia, N., Köber, M., Repetto, J., Pascarella, R., Soriano, A., Masanas, M., Segovia, N., Vargas‐Nadal, G., Merlo‐Mas, J., et al. (2021) · Small · doi:10.1002/smll.202101959 · Cited by 33 · see citing works

Oligonucleotide therapies for nonalcoholic steatohepatitis

Li, S., Xiong, F., Zhang, S., Liu, J., Gao, G., Xie, J. H., & Wang, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102184 · Cited by 32 · see citing works

Gene silencing approaches for the management of dyslipidaemia

Norata, G. D., Tibolla, G., & Catapano, A. L. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.010 · Cited by 30 · see citing works

Efficient Shielding of Polyplexes Using Heterotelechelic Polysarcosines

Klein, P. M., Klinker, K., Zhang, W., Kern, S., Kessel, E., Wagner, E., & Barz, M. (2018) · Polymers · doi:10.3390/polym10060689 · Cited by 28 · see citing works

Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects

Vaillant, A. (2022) · Viruses · doi:10.3390/v14092052 · Cited by 28 · see citing works

Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis

Khaja, F., Jayawardena, D., Kuzmis, A., & Önyüksel, H. (2016) · Nanomaterials · doi:10.3390/nano6010008 · Cited by 27 · see citing works

Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey

Jensen, K. K., Tadin‐Strapps, M., Wang, S., Hubert, J. A., Kan, Y., Ma, Y., McLaren, D. G., Previs, S. F., Herath, K. B., Mahsut, A., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m071498 · Cited by 27 · see citing works

Engineering Cell-Permeable Proteins through Insertion of Cell-Penetrating Motifs into Surface Loops

Chen, K., & Pei, D. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00593 · Cited by 25 · see citing works

Technologies for Investigating the Physiological Barriers to Efficient Lipid Nanoparticle–siRNA Delivery

Shi, B., & Abrams, M. T. (2013) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413484152 · Cited by 24 · see citing works

Current Approaches to Epigenetic Therapy

Griazeva, E. D., Fedoseeva, D. M., Radion, E. I., Ershov, P. V., Meshkov, I. O., Semyanihina, A. V., Makarova, A. S., Makarov, V. V., Yudin, V. S., Keskinov, A. A., et al. (2023) · Epigenomes · doi:10.3390/epigenomes7040023 · Cited by 23 · see citing works

Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and Rabbit

Chen, Z., Luo, B., Cai, T., Thankappan, A., Xu, Y., Wu, W., DiMuzio, J. M., Lifsted, T. Q., DiPietro, M., Disa, J., et al. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.75 · Cited by 23 · see citing works

Recent Advances in Lipid Nanoparticles: Nucleic Acid Therapeutics and Targeting Strategies

Sarmah, S., Baidya, S., & De, M. (2025) · Small · doi:10.1002/smll.202506812 · Cited by 25 · see citing works

Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy

Marschall, A. L. J. (2021) · BioDrugs · doi:10.1007/s40259-021-00500-y · Cited by 21 · see citing works

Toward understanding non-coding RNA roles in intracranial aneurysms and subarachnoid hemorrhage

Huang, F., Yi, J., Zhou, T., Gong, X., Jiang, H. F., & Yao, X. (2017) · Translational Neuroscience · doi:10.1515/tnsci-2017-0010 · Cited by 21 · see citing works

SiRNAs as antiviral drugs – Current status, therapeutic potential and challenges

Chokwassanasakulkit, T., Oti, V. B., Idris, A., & McMillan, N. A. J. (2024) · Antiviral Research · doi:10.1016/j.antiviral.2024.106024 · Cited by 19 · see citing works

Phosphorylation-specific status of RNAi triggers in pharmacokinetic and biodistribution analyses

Trubetskoy, V. S., Griffin, J. B., Nicholas, A. L., Nord, E. M., Xu, Z., Peterson, R. M., Wooddell, C. I., Rozema, D. B., Wakefield, D. H., Lewis, D. L., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw828 · Cited by 19 · see citing works

Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication

Dambra, R., Matter, A. M., Graca, K., Akhand, S. S., Mehta, S., Bell-Cohn, A. J., Swenson, J. M., Abid, S., Xin, D., Lewis, C., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.12.013 · Cited by 16 · see citing works

Advances in targeted delivery of small interfering RNA using simple bioconjugates

Nielsen, C., Kjems, J., Sørensen, K. R., Engelholm, L. H., & Behrendt, N. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.896898 · Cited by 16 · see citing works

RNA interference therapeutics for cardiac regeneration

Huntington, J., Pachauri, M., Ali, H., & Giacca, M. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.05.007 · Cited by 16 · see citing works

RNA interference-based technology: what role in animal agriculture?

Bradford, B. J., Cooper, C. A., Tizard, M. L., Doran, T. J., & Hinton, T. M. (2016) · Animal Production Science · doi:10.1071/an15437 · Cited by 16 · see citing works

Current state of RNA delivery using lipid nanoparticles to extrahepatic tissues: A review towards clinical translation

Truong, L. B., Medina-Cruz, D., & Mostafavi, E. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125185 · Cited by 14 · see citing works

Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease

Ahmed, T. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16336 · Cited by 16 · see citing works

New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases

Koenig, O., Walker, T., Perle, N., Zech, A., Neumann, B., Schlensak, C., Wendel, H.-P., & Nolte, A. (2013) · Pharmaceuticals · doi:10.3390/ph6070881 · Cited by 15 · see citing works

Nanoparticle-mediated delivery of siRNA into zebrafish heart: a cell-level investigation on the biodistribution and gene silencing effects

Wang, F., Wang, X., Gao, L., Meng, L.-Y., Xie, J.-M., Xiong, J., & Luo, Y. (2019) · Nanoscale · doi:10.1039/c9nr05758g · Cited by 15 · see citing works

Model‐Informed Drug Development Applications and Opportunities in mRNA ‐ LNP Therapeutics

Zhou, J., Rao, R. P., Shapiro, M. E., Tania, N., Herron, J. C., Musante, C. J., & Hughes, J. H. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3641 · Cited by 13 · see citing works

CRACC-CRACC Interaction between Kupffer and NK Cells Contributes to Poly I:C/D-GalN Induced Hepatitis

Li, Y., Cao, G., Zheng, X., Wang, J., Wei, H., Tian, Z., & Sun, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076681 · Cited by 13 · see citing works

Incorporation of a rhodamine B conjugated polymer for nanoparticle trafficking both in vitro and in vivo

Zhu, Y., Wang, J., Zhang, H., Khan, M. I., Du, X., & Wang, J. (2019) · Biomaterials Science · doi:10.1039/c9bm00032a · Cited by 13 · see citing works

Effects of Particle Size, Charge, Shape, Animal Disease State, and Sex on the Biodistribution of Intravenously Administered Nanoparticles

Ledford, B. T., Wyatt, T. G., Vang, J., Weiss, J. M., Tsihlis, N. D., & Kibbe, M. R. (2023) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.202300001 · Cited by 12 · see citing works

Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV

Bowden-Reid, E., Moles, E., Kelleher, A. D., & Ahlenstiel, C. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01788-x · Cited by 13 · see citing works

Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy

Alshehry, Y., Liu, X., Li, W., Wang, Q., Cole, J., & Zhu, G. (2025) · The AAPS Journal · doi:10.1208/s12248-025-01051-8 · Cited by 11 · see citing works

CXCL12 and IL7R as Novel Therapeutic Targets for Liver Hepatocellular Carcinoma Are Correlated With Somatic Mutations and the Tumor Immunological Microenvironment

He, K., Liu, S., Xia, Y., Xu, J., Liu, F., Xiao, J., Li, Y., Ding, Q., Lu, L., Xiang, G., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.574853 · Cited by 11 · see citing works

Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach

Coutinho, M. F., Santos, J. I., Mendonça, L. S., Matos, L., Prata, M. J., Jurado, A. S., de Lima, M. C. P., & Alves, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165732 · Cited by 10 · see citing works

siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys

Murphy, B. A., Tadin‐Strapps, M., Jensen, K., Mogg, R., Liaw, A. I., Herath, K. B., Bhat, G., McLaren, D. G., Previs, S. F., & Pinto, S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.02.015 · Cited by 10 · see citing works

Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters

Geisler, A., Dieringer, B., Elsner, L., Klingel, K., Klopfleisch, R., Vornlocher, H., Kurreck, J., & Fechner, H. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.016 · Cited by 9 · see citing works

Inflammatory and immune-mediated toxicity of lipid nanoparticles

Kim, S., Park, C., Lee, Y., Lee, K., Lee, H., & Lee, K. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119385 · Cited by 8 · see citing works

Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liability

Thankappan, A., Strapps, W. R., DiPietro, M. A., Leander, K. R., Zhang, Z., Shin, M. K., Levorse, J. M., Desai, K., Xu, Y., Lai, K., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-06-0505 · Cited by 8 · see citing works

Alterations in the hepatic transcriptional landscape after RNAi mediated ApoB silencing in cynomolgus monkeys

Hamza, M. S., Kumar, C., Chia, S. M., Anandalakshmi, V., Boo, N., Strapps, W. R., Robinson, M., Caguyong, M. J., Bartz, S. R., Tadin‐Strapps, M., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.032 · Cited by 7 · see citing works

Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems

Morales, L. C., Rajendran, A. P., Ansari, A. S., Remant, K. C., Nasrullah, M., Kiti, K., Yotsomnuk, P., Kulka, M., Sundaram, D. N. M., & Uludağ, H. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01077 · Cited by 7 · see citing works

Nanoformulations Downregulating METTL16 Combined with mRNA Tumor Vaccines Suppress Triple-Negative Breast Cancer and Prevent Metastasis

Wang, R., Zhang, Y., Du, S., Li, Y., Ren, Y., & Lin, J. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s520329 · Cited by 6 · see citing works

HIV Tat as a latency reversing agent: turning the tables on viral persistence

Fisher, B. M., Cevaal, P. M., Roche, M., & Lewin, S. R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1571151 · Cited by 5 · see citing works

Emerging Applications for High-Resolution MS in Discovery Bioanalysis

Emary, W. B., & Zhang, N. R. (2011) · Bioanalysis · doi:10.4155/bio.11.245 · Cited by 5 · see citing works

Aptamer-Targeted Dendrimersomes Assembled from Azido-Modified Janus Dendrimers “Clicked” to DNA

Bristow, P., Schantz, K., Moosbrugger, Z., Martin, K., Liebenberg, H., Steimle, S., Xiao, Q., Percec, V., & Wilner, S. E. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.3c01108 · Cited by 4 · see citing works

The phospholipid composition of artificial lipid droplets enhances their deliverability and facilitates a broad Biodistribution in vivo and in vitro

Telikani, Z., Amarasinghe, I., Impicciche, V., Nalbantlar, A., Whan, J., Caracciolo, K., Phillips, J., Dutton, J. L., Wallace, L., Jamal, A., et al. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.05.002 · Cited by 4 · see citing works

Ionic liquid-coated lipid nanoparticles demonstrate prolonged circulation and brain uptake via red blood cell hitchhiking

Khare, P., Edgecomb, S. X., Hamadani, C. M., Hu, D., Govindaswamy, B., Taylor, G. R., Caprara, R., Tanner, E. E. L., & Manickam, D. S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114487 · Cited by 4 · see citing works

Exploring dose and downregulation dynamics in lipid nanoparticles based siRNA therapy: Systematic review and meta-analysis

Kumar, A., Ahmed, B., Kaur, I. P., & Saha, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133984 · Cited by 4 · see citing works

Special Techniques in Toxicologic Pathology

Price, S. A., McDorman, K. S., Chan, C. M., Rojko, J. L., Raymond, J. T., Brown, D. L., Li, N., Satterwhite, C. M., Papenfuss, T. L., & Morrison, J. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821044-4.00032-7 · Cited by 3 · see citing works

The distribution and cell uptake of ApoA1 modified lipid carriers of siRNA in mouse liver in vivo

Li, Y., Rui, M., Tang, H., & Xu, Y. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.09.004 · Cited by 3 · see citing works

Utility of High‐Resolution Mass Spectrometry for New Drug Discovery Applications

Emary, W. B., & Zhang, N. R. (2013) · doi:10.1002/9781118516157.ch2 · Cited by 3 · see citing works

From mechanisms to applications: Research advances and translational prospects of endogenous targeting LNPs

Feng, Y., Zhao, Y., Han, J., Li, F., Li, G., Wang, B., Chen, Q., & Song, J. (2026) · Nano Research · doi:10.26599/nr.2026.94908571 · Cited by 2 · see citing works

Biodistribution and Metabolism Studies of Lipid Nanoparticle–Formulated Internally [3H]-Labeled siRNA in Mice

Christensen, J. K., Litherland, K., Faller, T., van de Kerkhof, E. G., Natt, F., Hunziker, J., Boos, J. A., Beuvink, I., Bowman, K., Baryza, J. L., et al. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055434 · Cited by 60 · see citing works

Technologies for Investigating the Physiological Barriers to Efficient Lipid Nanoparticle–siRNA Delivery

Shi, B., & Abrams, M. T. (2013) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413484152 · Cited by 24 · see citing works

Quantitation of Physiological and Biochemical Barriers to siRNA Liver Delivery via Lipid Nanoparticle Platform

Xu, Y., Ou, M., Keough, E., Roberts, J., Koeplinger, K., Lyman, M., Fauty, S. E., Carlini, E., Stern, M., Zhang, R., et al. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400584h · Cited by 38 · see citing works

Noninvasive Imaging of Lipid Nanoparticle–Mediated Systemic Delivery of Small-Interfering RNA to the Liver

Tao, W., Davide, J. P., Cai, M., Zhang, G., South, V. J., Matter, A. M., Ng, B., Zhang, Y., & Sepp‐Lorenzino, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.147 · Cited by 57 · see citing works

Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems

Morales, L. C., Rajendran, A. P., Ansari, A. S., Remant, K. C., Nasrullah, M., Kiti, K., Yotsomnuk, P., Kulka, M., Sundaram, D. N. M., & Uludağ, H. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01077 · Cited by 7 · see citing works